Edition:
United States

Intercept Pharmaceuticals Inc (ICPT.OQ)

ICPT.OQ on NASDAQ Stock Exchange Global Select Market

120.66USD
2:01pm EDT
Change (% chg)

$1.89 (+1.59%)
Prev Close
$118.77
Open
$118.00
Day's High
$120.92
Day's Low
$118.00
Volume
60,220
Avg. Vol
203,345
52-wk High
$124.38
52-wk Low
$51.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 43.58 -2.575
Mar '18 35.96 -3.224
FY 2017 Dec '17 37.69 -4.424
Sep '17 41.33 -2.892
Jun '17 30.89 -3.459
Mar '17 21.05 -3.607
FY 2016 Dec '16 13.81 -4.838
Sep '16 5.18 -3.590
Jun '16 5.52 -3.141
Mar '16 0.44 -5.171
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 17 49.20 55.70 44.51 64.03
Quarter Ending Dec-18 17 54.68 60.50 49.80 83.61
Year Ending Dec-18 18 183.65 195.70 175.60 245.17
Year Ending Dec-19 17 271.80 371.60 220.38 405.64
Earnings (per share)
Quarter Ending Sep-18 16 -2.50 -2.17 -3.04 -2.58
Quarter Ending Dec-18 16 -2.46 -2.00 -2.87 -2.25
Year Ending Dec-18 17 -10.71 -10.01 -11.66 -11.29
Year Ending Dec-19 16 -8.23 -3.76 -10.01 -7.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.50 32.14
P/E High - Last 5 Yrs. -- 275.43 47.40
P/E Low - Last 5 Yrs. -- 97.43 24.78
Beta -1.89 0.62 0.87
Price to Sales (TTM) 22.15 109.71 6.23
Price to Book (MRQ) 23.96 12.03 3.80
Price to Tangible Book (MRQ) 23.96 18.41 5.78
Price to Cash Flow (TTM) -- 59.58 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.55 -5.60
Payout Ratio(TTM) -- 5.86 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 41.08 174.85 8.41
Sales (TTM) vs TTM 1 Yr. Ago 123.57 91.86 6.69
Sales - 5 Yr. Growth Rate 121.68 24.26 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 25.54 272.94 25.39
EPS (TTM) vs TTM 1 Yr. Ago 15.36 -- --
EPS - 5 Yr. Growth Rate -- 23.39 7.57
Capital Spending - 5 Yr. Growth Rate 205.90 38.46 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.18
Current Ratio (MRQ) 6.51 5.48 2.95
LT Debt to Equity (MRQ) 247.86 14.97 11.33
Total Debt to Equity (MRQ) 247.86 18.40 14.17
Interest Coverage (TTM) -12.60 -204.17 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 98.75 55.80 54.77
Gross Margin - 5 Yr. Avg. -- 52.46 53.26
EBITD Margin (TTM) -196.28 -- --
EBITD - 5 Yr. Avg -656.74 -175.51 15.90
Operating Margin (TTM) -199.53 -608.67 3.68
Operating Margin - 5 Yr. Avg. -691.09 -189.07 11.01
Pre-Tax Margin (TTM) -214.85 -605.68 3.97
Pre-Tax Margin - 5 Yr. Avg. -833.46 -191.53 11.18
Net Profit Margin (TTM) -214.85 -601.23 0.71
Net Profit Margin - 5 Yr. Avg. -833.46 -189.32 7.52
Effective Tax Rate (TTM) -- 11.41 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 312,740 5,162,908 710,435,462
Net Income/Employee (TTM) -671,905 -6,026,407 81,903,466
Receivable Turnover (TTM) 9.69 5.43 5.02
Inventory Turnover (TTM) -- 2.04 3.62
Asset Turnover (TTM) 0.26 0.37 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.82 0.74 9.68
Return on Assets - 5 Yr. Avg. -64.39 2.54 10.88
Return on Investment (TTM) -65.24 1.52 12.66
Return on Investment - 5 Yr. Avg. -71.49 2.08 14.01
Return on Equity (TTM) -215.41 0.25 14.84
Return on Equity - 5 Yr. Avg. -106.22 -1.25 15.40
  1 Year 3 Year 5 Year
Sales % 424.85 322.08 121.68
EPS (TTM) % 14.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intercept Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.89 13.62 84 95
13 Week 44.42 38.67 93 72
26 Week 87.45 76.04 93 44
52 Week 25.18 8.34 70 88
YTD 103.30 88.16 93 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.96%
# of Holders: 261
Total Shares Held: 20,980,474
3 Mo. Net Change: 934,317
# New Positions: 39
# Closed Positions: 24
# Increased Positions: 116
# Reduced Positions: 91
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.